Improving COVID-19 antibody testing in African American communities
Culturally-targeted communication to promote SARS-CoV-2 antibody testing in saliva: Enabling evaluation of inflammatory pathways in COVID-19 racial disparities
This study is all about helping African American communities get tested for COVID-19 by using friendly communication and easy saliva tests, so we can better understand and reduce the differences in infection rates.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10688350 on NIH RePORTER |
What this research studies
This research aims to address the disparities in SARS-CoV-2 infection rates among African Americans by promoting the uptake of antibody testing through culturally-targeted communication. The study will utilize non-invasive saliva tests to evaluate inflammatory responses related to COVID-19, focusing on the unique needs and concerns of African American communities. By understanding and addressing the barriers to testing, the research seeks to enhance participation and ultimately reduce health disparities. The approach combines effective health communication strategies with innovative testing methods to foster trust and engagement.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American individuals who may have been affected by COVID-19 or are interested in understanding their antibody status.
Not a fit: Patients who are not African American or those who have no interest in COVID-19 antibody testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased participation in antibody testing among African Americans, helping to identify and address COVID-19-related health disparities.
How similar studies have performed: Previous research has shown that culturally-targeted health interventions can improve participation rates in medical testing among marginalized communities, suggesting a promising approach.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Lucas, Todd William — Michigan State University
- Study coordinator: Lucas, Todd William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.